Advertisement
Loading...

BridgeBio Pharma, Inc.

BBIO•NASDAQ
Healthcare
Biotechnology
$66.92
$-1.69(-2.46%)
U.S. Market is Open • 15:43

BridgeBio Pharma, Inc. (BBIO) Stock Overview

Explore BridgeBio Pharma, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap13.6B
P/E Ratio-18.72
EPS (TTM)$-3.74
ROE0.36%
Fundamental Analysis

AI Price Forecasts

1 Month$64.32
3 Months$80.14
1 Year Target$73.29

BBIO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BridgeBio Pharma, Inc. (BBIO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.97, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $73.29.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -18.72 and a market capitalization of 13.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.53%
5-Day Change
4.70%
1-Month Change
-10.61%
3-Month Change
-7.43%
6-Month Change
4.93%
Year-to-Date (YTD) Change
-8.93%
1-Year Change
106.95%
3-Year Change
369.41%
5-Year Change
29.82%
All-Time (Max) Change
152.85%

Contact Information

https://www.bridgebio.com
650 391 9740
421 Kipling Street, Palo Alto, CA, 94301

Company Facts

725 Employees
IPO DateJun 27, 2019
CountryUS
Actively Trading

Frequently Asked Questions